Tag: European Medicines Agency
CHMP Adopts Positive Opinion for Belantamab Mafodotin, Recommending Approval for the...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of...
Positive Phase III ECHELON-1 Trial Data Leads to FDA Breakthrough Therapy...
U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to brentuximab vedotin (Adcetris®; Seattle Genetics) in combination with chemotherapy for the frontline...